Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.

Javed AkhtarRatna PriyaVaishali JainPuja SakhujaAnil Kumar AgarwalSurbhi GoyalRavindra Varma PolisettyRavi SirdeshmukhSudeshna KarPoonam Gautam

Published in: BMC cancer (2020)

The study suggests that the ANXA1 autoantibody levels against ANXA1 may be potentially employed for early stage detection of GBC patients. Other proteins could also be explored and verified in a large cohort of clinical samples.

Keyphrases

early stage
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
sentinel lymph node
peritoneal dialysis
single cell
patient reported outcomes
patient reported
label free
quantum dots